Fingerprint
Dive into the research topics of 'Phase II trial of nafamostat mesilate/ gemcitabin/S-1 for unresectable pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of nafamostat mesilate/ gemcitabin/S-1 for unresectable pancreatic cancer
Tadashi Uwagawa*, Taro Sakamoto, Takeshi Gocho, Hiroaki Shiba, Shinji Onda, Jungo Yasuda, Yoshihiro Shirai, Ryoga Hamura, Kenei Furukawa, Katsuhiko Yanaga, Toru Ikegami
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations